GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Debt-to-Revenue

Alpa Laboratories (NSE:ALPA) Debt-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Alpa Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Alpa Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Alpa Laboratories's annualized Revenue for the quarter that ended in Dec. 2023 was ₹1,092 Mil. Alpa Laboratories's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.


Alpa Laboratories Debt-to-Revenue Historical Data

The historical data trend for Alpa Laboratories's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Debt-to-Revenue Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 - 0.05 0.03

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.02 - 0.01 -

Competitive Comparison of Alpa Laboratories's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Debt-to-Revenue falls into.



Alpa Laboratories Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Alpa Laboratories's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(15.269 + 7.771) / 924.102
=0.02

Alpa Laboratories's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 1092.332
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Alpa Laboratories Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (NSE:ALPA) Business Description

Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.